# OnCo record komal-jhaveri (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/komal-jhaveri/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "komal-jhaveri" ;
  schema:name "Komal Jhaveri"@en ;
  schema:description "Leads the next wave of endocrine therapy: oral SERDs like imlunestrant and the PI3K inhibitor inavolisib."@en ;
  schema:url <https://onco.cc/people/komal-jhaveri/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Jhaveri%20K%5BAuthor%5D%20breast%20SERD> ;
  onco:tag "breast", "endocrine", "early-phase" ;
  schema:jobTitle "Section Head, Endocrine Therapy Research, Memorial Sloan Kettering Cancer Center" ;
  onco:cancers <https://onco.cc/cancers/breast-hr-positive/> ;
  onco:technologies <https://onco.cc/technologies/endocrine-therapy/>, <https://onco.cc/technologies/protac-degrader/> ;
  onco:targets <https://onco.cc/targets/estrogen-receptor/>, <https://onco.cc/targets/pik3ca/> ;
  onco:drugs <https://onco.cc/drugs/inavolisib/>, <https://onco.cc/drugs/palbociclib/>, <https://onco.cc/drugs/abemaciclib/> ;
  onco:institutions <https://onco.cc/institutions/mskcc/> ;
  onco:trials <https://onco.cc/trials/ember-3/>, <https://onco.cc/trials/inavo120/> ;
  schema:affiliation <https://onco.cc/institutions/mskcc/> .